{"id":"NCT00417963","sponsor":"C. R. Bard","briefTitle":"ViVEXX Carotid Revascularization Trial (VIVA)","officialTitle":"The ViVEXX Carotid Revascularization Trial (VIVA) for High Surgical Risk Patients With Extracranial Carotid Artery Stenosis Using the Bard ViVEXX Carotid Stent and Emboshield BareWire Rapid Exchange Embolic Protection System","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10","primaryCompletion":"2009-01","completion":"2010-03","firstPosted":"2007-01-04","resultsPosted":"2011-07-20","lastUpdate":"2017-03-01"},"enrollment":407,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Carotid Artery Stenosis"],"interventions":[{"type":"DEVICE","name":"Carotid Artery Stenting","otherNames":["CAS"]}],"arms":[{"label":"stent placement in the carotid artery","type":"EXPERIMENTAL"}],"summary":"To evaluate the safety and efficacy of the Bard ViVEXX Carotid Stent and Emboshield BareWire Rapid Exchange Embolic Protection System in the treatment of extracranial carotid artery stenosis in patients at high risk for carotid endarterectomy.","primaryOutcome":{"measure":"Percentage of Patients Experiencing Major Adverse Events (MAE)","timeFrame":"365 days from implantation","effectByArm":[{"arm":"ViVexx Carotid Stent Group","deltaMin":6.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":316,"n":486},"commonTop":["Hypotension","Anaemia","CArdiac failure congestive","Mycardial infarction","Hypertension"]}}